GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008709 describes the NAD+-dependent oxidation of cholate to 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate, a key step in bile acid and steroid metabolism.
• The enzyme is a 7alpha-hydroxysteroid dehydrogenase (7alpha-HSDH) found in gut bacteria such as Bacteroides fragilis and Clostridium absonum, where multiple forms exist.
• Activity is inducible by bile salts, linking the enzyme directly to bile acid deconjugation and 7alpha-dehydroxylation pathways.
• NAD+ availability and the cellular redox state regulate flux through this reaction, connecting it to mitochondrial NAD kinase and sirtuin biology.
• Loss or inhibition of 7alpha-HSDH alters bile acid pools, which can influence hepatic steatosis, fibrosis, and colorectal cancer risk.
• CRISPR knockout, point-mutation, and overexpression models are essential to dissect the enzyme's role in host-microbe bile acid crosstalk.
Description
Cholate 7-alpha-dehydrogenase (NAD+) activity, encoded by GO:0008709, is a molecular function that catalyzes the reversible oxidation of cholate to 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate using NAD+ as the electron acceptor. This reaction is a critical entry point for microbial bile acid transformation in the gut, where 7alpha-hydroxysteroid dehydrogenases (7alpha-HSDHs) modify host-derived bile acids and influence their signaling properties. The enzyme belongs to the short-chain dehydrogenase/reductase family and is widely distributed among anaerobic bacteria, including Bacteroides fragilis and Clostridium absonum. Researchers study GO:0008709 because it sits at the interface of microbial metabolism and human physiology: the products of this reaction feed into secondary bile acid synthesis, which modulates nuclear receptor signaling, lipid homeostasis, and immune responses. Understanding its catalytic mechanism, regulation, and genetic determinants is therefore relevant to hepatology, gastroenterology, and oncology.
cholate 7-alpha-dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0008709 |
|---|---|
| GO term | cholate 7-alpha-dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | 7alpha-HSDH; 7-alpha-hydroxysteroid dehydrogenase activity; 7alpha-hydroxysteroid dehydrogenase activity; 7alpha-hydroxysteroid:NAD+ 7-oxidoreductase activity |
| Major function | NAD+-dependent oxidation of cholate to 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate |
| Reaction direction | Reversible; forward reaction consumes NAD+ and produces NADH |
| Substrate | Cholate (a primary bile acid) |
| Product | 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide, oxidized form) |
| Cellular context | Bacterial bile acid metabolism; gut microbial transformation |
What Is GO:0008709?
GO:0008709 is defined by the QuickGO ontology as the catalysis of the reaction: cholate + NAD+ = 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate + H+ + NADH. In other words, it is an oxidoreductase activity that removes a hydride from the 7alpha position of cholate, transferring it to NAD+ and producing a 7-oxo bile acid intermediate plus NADH. The term is synonymous with 7alpha-HSDH, 7alpha-hydroxysteroid dehydrogenase, and 7alpha-hydroxysteroid:NAD+ 7-oxidoreductase activity.
Why Is cholate 7-alpha-dehydrogenase (NAD+) activity Important in Cell Biology?
GO:0008709 is important because it controls a rate-limiting step in the microbial conversion of primary bile acids into secondary bile acids, which are potent signaling molecules in human health and disease. By oxidizing cholate to a 7-oxo intermediate, the enzyme sets the stage for subsequent 7alpha-dehydroxylation, a pathway that generates deoxycholic acid and lithocholic acid, known modulators of farnesoid X receptor (FXR) and G protein-coupled bile acid receptor (TGR5) signaling. Dysregulation of this activity has been linked to altered bile acid pools, hepatic steatosis, fibrosis, and colorectal carcinogenesis, making it a target for microbiome-directed therapeutics and biomarker discovery.
• Controls a key step in bile acid 7alpha-dehydroxylation, affecting secondary bile acid production.
• Influences host lipid and glucose metabolism through bile acid receptor signaling.
• Modulates gut microbial community composition by altering bile acid toxicity.
• Linked to hepatic steatosis and fibrosis in preclinical models.
• Potential role in colorectal cancer risk via secondary bile acid generation.
• Provides a model for studying NAD+-dependent oxidoreductases and cofactor balance.
• Relevant to probiotic and live biotherapeutic design targeting bile acid metabolism.
• Enables mechanistic studies of host-microbe metabolic crosstalk.
• Serves as a target for small-molecule inhibitors or activators in metabolic disease.
• Supports development of CRISPR-engineered bacterial strains for functional genomics.
Molecular Mechanism of cholate 7-alpha-dehydrogenase (NAD+) activity
Substrate recognition and binding
In simple terms: The enzyme grabs cholate and holds it in place so it can remove a hydrogen atom.
The 7alpha-HSDH enzyme binds cholate through a conserved substrate-binding pocket that positions the 7alpha-hydroxyl group near the catalytic tyrosine residue. Bacterial 7alpha-HSDHs from Bacteroides fragilis show multiple forms with distinct substrate affinities, suggesting structural adaptations for different bile acid substrates. Bile salt induction of 7alpha- and 7beta-HSDH activities in Clostridium absonum indicates that substrate availability and gene regulation are tightly coupled.
NAD+ binding and hydride transfer
In simple terms: NAD+ acts as a shuttle that carries away electrons from the bile acid.
The enzyme uses NAD+ as a cofactor, binding it in a Rossmann-fold domain typical of short-chain dehydrogenases. Catalysis proceeds via hydride transfer from the 7alpha position of cholate to the nicotinamide ring of NAD+, yielding NADH and a 7-oxo intermediate. The reaction is reversible, and the equilibrium can shift based on NAD+/NADH ratios in the bacterial cell.
Catalytic residues and mechanism
In simple terms: A few key amino acids in the enzyme do the chemical work of breaking the bond.
A conserved tyrosine and lysine pair forms the catalytic dyad that stabilizes the transition state during hydride transfer. Mutational studies of related 7alpha-HSDHs have shown that altering these residues abolishes activity, confirming their essential role. The enzyme's stereospecificity for the 7alpha position distinguishes it from 7beta-HSDHs, which act on the opposite face of the steroid nucleus.
Cofactor regeneration and redox balance
In simple terms: The cell must recycle NAD+ to keep the reaction going.
NAD+ regeneration is critical for sustained 7alpha-HSDH activity, linking this enzyme to cellular NAD+ salvage and biosynthesis pathways. Mitochondrial NAD kinase deficiency alters NAD+ pools and can indirectly affect oxidoreductase fluxes, as shown in hepatic steatosis models. Sirtuin 6, an NAD+-dependent deacetylase, modulates fibrogenic signaling, highlighting the broader redox context in which 7alpha-HSDH operates.
Regulation by bile salts and host factors
In simple terms: Bile acids themselves can turn the enzyme on or off.
Bile salts induce both 7alpha- and 7beta-HSDH activities in Clostridium absonum, demonstrating substrate-level regulation. In Bacteroides fragilis, multiple enzyme forms are expressed under different growth conditions, suggesting differential regulation. Host-derived factors such as NAD+ availability and inflammatory signals can further modulate enzyme activity in the gut environment.
Key Genes Involved in GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity
The following genes and proteins are directly or functionally associated with cholate 7-alpha-dehydrogenase (NAD+) activity, based on published biochemical and genetic studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| 7alpha-HSDH (Bacteroides fragilis) | Catalyzes cholate oxidation using NAD+ | Model enzyme for multiple forms and substrate specificity |
| 7alpha-HSDH (Clostridium absonum) | Bile salt-inducible 7alpha-dehydrogenase | Studying bile induction and 7beta-HSDH co-regulation |
| 7beta-HSDH (Clostridium absonum) | Epimer-specific dehydrogenase | Comparative mechanism and substrate recognition |
| NADK (mitochondrial NAD kinase) | Maintains NAD+ pools | Links cofactor supply to oxidoreductase activity |
| SIRT6 | NAD+-dependent deacetylase | Connects redox state to fibrogenic signaling |
| NAD+ salvage pathway enzymes | Recycle NAD+ | Support sustained 7alpha-HSDH flux |
| Bile acid transporters (e.g., ASBT, NTCP) | Regulate bile acid availability | Determine substrate supply for 7alpha-HSDH |
| FXR (NR1H4) | Bile acid nuclear receptor | Mediates downstream effects of bile acid pool changes |
| TGR5 (GPBAR1) | Bile acid G protein-coupled receptor | Links secondary bile acids to metabolic signaling |
| YAP/TAZ | Hippo pathway effectors | Modulated by SIRT6 in fibrosis, relevant to bile acid stress |
| Adenylate cyclase regulatory component | G protein signaling | General redox and signaling context |
| Cellular retinol-binding protein (CRBP) | Retinoid metabolism | Example of steroid/retinoid dehydrogenase family |
| 17alpha-estradiol dehydrogenase | Steroid oxidation | Comparative steroid dehydrogenase mechanism |
| 17beta-estradiol dehydrogenase | Steroid oxidation | Comparative steroid dehydrogenase mechanism |
| Membrane-bound lactate dehydrogenase | Oxidoreductase | Model for membrane-associated dehydrogenases |
| Mandelate dehydrogenase | Oxidoreductase | Model for substrate specificity in dehydrogenases |
How Is cholate 7-alpha-dehydrogenase (NAD+) activity Regulated?
Regulation of cholate 7-alpha-dehydrogenase (NAD+) activity occurs at multiple levels. In bacteria, enzyme expression is induced by bile salts, as demonstrated for both 7alpha- and 7beta-HSDH in Clostridium absonum. Multiple forms of the enzyme in Bacteroides fragilis suggest differential regulation by growth phase or substrate availability. At the metabolic level, NAD+ availability controls flux through the reaction; mitochondrial NAD kinase deficiency alters NAD+ pools and can affect oxidoreductase-dependent processes. Sirtuin 6, an NAD+-dependent deacetylase, modulates fibrogenic signaling and may indirectly influence bile acid metabolism through redox and transcriptional networks. Host inflammatory and metabolic signals can also shape the gut environment, thereby affecting enzyme activity.
cholate 7-alpha-dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| 7alpha-HSDH (Bacteroides fragilis) | Bile acid metabolism, colorectal cancer | Bacterial knockout and mouse colonization |
| 7alpha-HSDH (Clostridium absonum) | Bile acid transformation | In vitro enzyme assays and bile induction |
| NADK | Hepatic steatosis | Liver-specific knockout mouse |
| SIRT6 | Hepatic fibrosis | SIRT6 knockout and overexpression models |
| FXR | Metabolic syndrome | FXR knockout mouse and agonist treatment |
Hepatic steatosis and fibrosis
Altered bile acid metabolism, including changes in 7alpha-HSDH activity, has been linked to hepatic steatosis. Mitochondrial NAD kinase deficiency causes stress-induced hepatic steatosis in mice, implicating NAD+ balance in liver lipid accumulation. Sirtuin 6 protects against hepatic fibrogenesis by suppressing YAP and TAZ function, connecting NAD+-dependent pathways to liver fibrosis. These findings suggest that dysregulated 7alpha-HSDH activity could contribute to bile acid pool changes that promote liver disease.
Colorectal cancer
Secondary bile acids produced via 7alpha-dehydroxylation pathways, which depend on 7alpha-HSDH activity, have been implicated in colorectal carcinogenesis. The enzyme's products can act as tumor promoters or modulators of apoptosis in colonocytes. Studying 7alpha-HSDH in gut bacteria may reveal mechanisms linking microbiome composition to cancer risk.
Metabolic syndrome and inflammation
Bile acids are signaling molecules that regulate glucose and lipid homeostasis through FXR and TGR5. Changes in 7alpha-HSDH activity alter the ratio of primary to secondary bile acids, potentially affecting insulin sensitivity and inflammation. NAD+ redox imbalance, as seen in NAD kinase deficiency, can exacerbate metabolic stress.
From cholate 7-alpha-dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of 7alpha-HSDH alter bile acid pools? | Bacterial knockout (CRISPR) in Bacteroides fragilis |
| What is the catalytic role of conserved tyrosine? | Point mutation in recombinant 7alpha-HSDH |
| Can we track enzyme localization in gut bacteria? | Tagged knock-in with fluorescent protein |
| Does overexpression change secondary bile acid production? | Overexpression in Clostridium absonum |
| Which host genes respond to altered bile acids? | Mouse colonization with mutant bacteria + RNA-seq |
| Is NAD+ availability limiting for enzyme activity? | NADK knockout or overexpression in hepatic cells |
How to Study the cholate 7-alpha-dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity | Purified 7alpha-HSDH kinetics |
| LC-MS bile acid profiling | Substrate and product levels | Bacterial culture and fecal samples |
| CRISPR knockout | Gene function | Bacteroides fragilis 7alpha-HSDH |
| Site-directed mutagenesis | Catalytic residue importance | Recombinant enzyme |
| RNA-seq | Transcriptional response | Host and microbial gene expression |
| Metagenomics | Microbial community composition | Gut microbiome studies |
| NAD+/NADH ratio assay | Redox state | Cofactor availability |
| Western blot | Protein expression | Enzyme levels in bacteria |
Enzymatic activity assays
Direct measurement of 7alpha-HSDH activity using cholate and NAD+ as substrates, monitoring NADH formation at 340 nm. This method is standard for characterizing purified enzymes from Bacteroides fragilis and Clostridium absonum.
Bile acid profiling by mass spectrometry
LC-MS or GC-MS quantification of cholate, 7-oxo intermediates, and secondary bile acids in bacterial cultures or biological samples. This approach reveals the metabolic impact of 7alpha-HSDH activity.
CRISPR-based bacterial genetics
Knockout or point mutation of 7alpha-HSDH genes in gut bacteria to test function in vivo. This enables causal links between enzyme activity and host phenotypes.
Transcriptomics and metatranscriptomics
RNA-seq of bacterial communities or host tissues to identify genes co-regulated with 7alpha-HSDH, including NAD+ salvage and bile acid transporters.
How CRISPR Can Be Used to Study GO:0008709 cholate 7-alpha-dehydrogenase (NAD+) activity
Knockout
CRISPR knockout of 7alpha-HSDH genes in Bacteroides fragilis or Clostridium absonum can abolish enzyme activity, allowing researchers to test its role in bile acid transformation and host-microbe interactions. Knockout strains can be colonized into gnotobiotic mice to assess effects on bile acid pools and liver disease models.
Point Mutation
Introducing point mutations in catalytic residues (e.g., tyrosine to phenylalanine) via CRISPR base editing or homology-directed repair can dissect the mechanism of hydride transfer and substrate specificity. Such mutants are valuable for structure-function studies.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous 7alpha-HSDH locus enables real-time tracking of enzyme expression and localization in live bacteria. This approach can reveal spatiotemporal regulation in the gut.
Overexpression
CRISPR activation or plasmid-based overexpression of 7alpha-HSDH can increase flux through the bile acid 7alpha-dehydroxylation pathway, producing higher levels of secondary bile acids for functional studies. This is useful for testing dose-dependent effects on host physiology.
How EDITGENE Supports cholate 7-alpha-dehydrogenase (NAD+) activity Research
Researchers studying cholate 7-alpha-dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in bile acid metabolism, liver disease, or microbiome-host crosstalk. EDITGENE provides CRISPR-based cell and bacterial models to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for cholate 7-alpha-dehydrogenase (NAD+) activity research.
Frequently Asked Questions About cholate 7-alpha-dehydrogenase (NAD+) activity
What is cholate 7-alpha-dehydrogenase (NAD+) activity?
It is an enzyme activity defined by GO:0008709 that catalyzes the NAD+-dependent oxidation of cholate to 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate, a key step in bile acid metabolism.
What genes are involved in cholate 7-alpha-dehydrogenase (NAD+) activity?
Genes encoding 7alpha-hydroxysteroid dehydrogenases in bacteria such as Bacteroides fragilis and Clostridium absonum, as well as NAD+ salvage genes like NADK and SIRT6, are functionally linked.
What is the reaction catalyzed by GO:0008709?
The reaction is: cholate + NAD+ = 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate + H+ + NADH.
Which organisms have cholate 7-alpha-dehydrogenase activity?
It is found in anaerobic gut bacteria, including Bacteroides fragilis and Clostridium absonum, where multiple enzyme forms exist.
How is 7alpha-HSDH activity regulated?
It is induced by bile salts and influenced by NAD+ availability and redox state, with multiple forms expressed under different conditions.
What diseases are associated with altered 7alpha-HSDH activity?
Changes in bile acid metabolism linked to this activity have been associated with hepatic steatosis, fibrosis, and colorectal cancer risk.
How can I study cholate 7-alpha-dehydrogenase (NAD+) activity in the lab?
Common methods include NADH absorbance assays, LC-MS bile acid profiling, CRISPR knockout in bacteria, and RNA-seq.
What is the role of NAD+ in GO:0008709?
NAD+ serves as the electron acceptor, accepting a hydride from cholate to form NADH, which must be regenerated for sustained activity.
Are there multiple forms of 7alpha-HSDH?
Yes, multiple forms of 7alpha-hydroxysteroid dehydrogenase have been identified in Bacteroides fragilis, with distinct properties.
Can CRISPR be used to study 7alpha-HSDH function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of 7alpha-HSDH in bacteria and host cells.
Conclusion
GO:0008709, cholate 7-alpha-dehydrogenase (NAD+) activity, is a central enzymatic function in microbial bile acid metabolism with far-reaching implications for human health. Its ability to oxidize cholate using NAD+ influences secondary bile acid production, host signaling, and disease risk. Continued research using CRISPR models and multi-omics approaches will clarify its mechanistic roles and therapeutic potential.
References
- 1. Hylemon PB et al.. 1975. Multiple forms of 7-alpha-hydroxysteroid dehydrogenase in selected strains of Bacteroides fragilis.. J Bacteriol 122(2):418-24 PMID: 236279
- 2. MacDonald IA et al.. 1981. Bile induction of 7 alpha- and 7 beta-hydroxysteroid dehydrogenases in Clostridium absonum.. Biochim Biophys Acta 665(2):262-9 PMID: 6945134
- 3. Zhang K et al.. 2018. Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice.. Gastroenterology 154(1):224-237 PMID: 28923496
- 4. Chowdhury K et al.. 2022. Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function.. FASEB J 36(10):e22529 PMID: 36036554
- 5. Northup JK et al.. 1980. Purification of the regulatory component of adenylate cyclase.. Proc Natl Acad Sci U S A 77(11):6516-20 PMID: 6935665
- 6. Napoli JL et al.. 1991. Physiological occurrence, biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis.. Biomed Pharmacother 45(4-5):131-43 PMID: 1932598
- 7. Henderson LL et al.. 1984. Purification and characterization of epimeric estradiol dehydrogenases (17 alpha and 17 beta) from equine placenta.. Biochemistry 23(3):486-91 PMID: 6584179
- 8. Allison N et al.. 1985. Membrane-bound lactate dehydrogenases and mandelate dehydrogenases of Acinetobacter calcoaceticus. Location and regulation of expression.. Biochem J 227(3):753-7 PMID: 3890833
